CIA
GOSS icon

Cape Investment Advisory’s Gossamer Bio GOSS Stock Holding History

Cape Investment Advisory’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-88
Closed -$6.31K – 969
2024
Q2 		$6.31K Buy
+88
New +$5.27K ﹤0.01% 609

Other funds holding GOSS

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Cape Investment Advisory's GOSS Position: Q3 2024 in Review

Cape Investment Advisory sold out of Gossamer Bio (GOSS) in Q3 2024, closing a stake of 88 shares — an estimated $6.31K sold.

Cape Investment Advisory first reported a position in GOSS in Q2 2024 and held it in 1 quarter. The position peaked at $6.31K in Q2 2024. 99 funds tracked by Wall St. Rank hold GOSS as of Q3 2024.

  • Cape Investment Advisory reported no remaining Gossamer Bio position as of Q3 2024 after selling out during the quarter.
  • Cape Investment Advisory sold 88 Gossamer Bio shares in Q3 2024, an estimated $6.31K.
  • Cape Investment Advisory first reported a position in Gossamer Bio in Q2 2024 and held it in 1 quarter.
  • Cape Investment Advisory's Gossamer Bio position peaked at $6.31K in Q2 2024.
  • 99 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2024.

Based on Cape Investment Advisory's 13F filing for Q3 2024, filed 14 Nov 2024.